Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETEPLIRSEN vs ETESEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ETEPLIRSEN vs ETESEVIMAB: Safety Overview

Metric ETEPLIRSEN ETESEVIMAB
Total FAERS Reports 2,079 1,188
Deaths Reported 59 67
Death Rate 2.8% 5.6%
Hospitalizations 288 374
Average Patient Age 15.5 yrs 54.0 yrs
% Female Patients 1.7% 61.7%
FDA Approval Date Sep 19, 2016 N/A
Manufacturer Sarepta Therapeutics, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A